This is a news story, published by CNBC, that relates primarily to Starboard Value news.
For more Starboard Value news, you can click here:
more Starboard Value newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Activist investor Starboard Value. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest drugmaker Pfizer news, Pfizer spokesperson news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pharmaceutical giant PfizerCNBC
•
73% Informative
Activist investor Starboard Value has a roughly $1 billion stake in pharmaceutical giant Pfizer .
The activist fund is looking to tap former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio .
Pfizer has begun to cut costs aggressively as demand for its Covid-19 medicines continues to recede.
VR Score
82
Informative language
85
Neutral language
57
Article tone
formal
Language
English
Language complexity
47
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links